Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors
This study is currently recruiting participants.
Verified December 2016 by Ayman Saad, University of Alabama at Birmingham
Miltenyi Biotec, Inc.
Information provided by (Responsible Party):
Ayman Saad, University of Alabama at Birmingham
First received: August 12, 2009
Last updated: December 27, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||October 2018|
|Estimated Primary Completion Date:||October 2017 (Final data collection date for primary outcome measure)|